Senior insider sale
XERIS BIOPHARMA HOLDINGS, INC. — senior position signals high conviction
$977.0K
135.40K shares
What this filing means
JOHNSON JOHN plans to sell 135.40K shares of XERIS BIOPHARMA HOLDINGS, INC. valued at approximately $977.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/19/2025ACC: 0001950047-25-010581
Director
Since Oct 2021
135.40K
Shares to sell
$977.0K
Approx. market value
135.40K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Restricted Stock
Not Applicable
3/22/2024
17.69KRestricted Stock
Not Applicable
7/2/2021
83.60KRestricted Stock
Not Applicable
4/8/2021
34.11KTotal acquired135.40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/22/2024 | Restricted Stock Not Applicable | 17.69K | — |
7/2/2021 | Restricted Stock Not Applicable | 83.60K | — |
4/8/2021 | Restricted Stock Not Applicable | 34.11K | — |
| Total | 135.40K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
135.40K
Market value
$977.0K
12/19/2025
Total
Units
135.40K
Value
$977.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/19/2025 | 135.40K | $977.0K | NASDAQ | Planned |
| Total | 135.40K | $977.0K | ||